Prevalence of migraine and co-morbid psychiatric disorders among students of Cumhuriyet University

Murat Semiz, Ilteriş Ahmet Şentürk, Hatice Balaban, Ayşegül Kartal Yağız, Önder Kavakçı, Murat Semiz, Ilteriş Ahmet Şentürk, Hatice Balaban, Ayşegül Kartal Yağız, Önder Kavakçı

Abstract

Background: The aim of this study was to investigate the prevalence of migraine and associated psychiatric disorders among university students at Cumhuriyet University of Sivas in Turkey.

Methods: A total of 1601 university students participated in this study and answered the questionnaires. The study was conducted in three stages: the self-questionnaire, the neurological evaluation, and the psychiatric evaluation. In the first stage, the subjects completed a questionnaire to assess migraine symptoms. In the second stage, the subjects who reported having migraines underwent a detailed neurological evaluation conducted by a neurologist to confirm the diagnosis. In the final stage, the subjects with migraines completed a psychiatric examination using the structured clinical interview for DSM IV-R Axis I.

Results: The self-reported migraine prevalence rate was 13.7%, and the actual prevalence rate of migraine among the university students was calculated to be 10.6% (n=169). When the results obtained with the SCID-I were examined, a current SCID-I psychiatric diagnosis was found in 39 (23.1%) of the 169 subjects with migraines. A total of 73 (43.2%) students with migraines had a lifetime SCID-I psychiatric diagnosis.

Conclusions: The results of this study indicate that migraines were highly prevalent among university students in Turkey with comorbid psychiatric disorders. Treatment strategies must be developed to manage these comorbidities.

References

    1. Kurt S, Kaplan Y. Epidemiological and clinical characteristics of headache in university students. Clin Neurol Neurosurg. 2008;14:46–50. doi: 10.1016/j.clineuro.2007.09.001.
    1. Demirkırkan MK, Ellidokus H, Boluk E. Prevalence and clinical characteristics of migraine in university students in Turkey. Thoku J Exp Med. 2006;14:87–92. doi: 10.1620/tjem.208.87.
    1. Adoukonou T, Houinato D, Kankouan J, Makoutode M, Paraiso M, Tehindrazanarivelo A, Viader F, Preux PM. Migraine among university students in Cotonou (Benin) Headache. 2009;14:887–893. doi: 10.1111/j.1526-4610.2009.01408.x.
    1. Breslau N, Rasmussen BK. The impact of migraine: epidemiology, risk factors and comorbidities. Neurology. 2001;14:4–12. doi: 10.1212/WNL.56.1.4.
    1. Zarifoğlu M, Karli N, Tas¸ kapilioğlu O. Can ID migraine be used as a screening test for adolescent migraine? Cephalalgia. 2008;14:65–71.
    1. Ertas M, Baykan B, Orhan EK, Zarifoglu M, Karli N, Saip S, Onal AE, Siva A. One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain. 2012;14:147–157. doi: 10.1007/s10194-011-0414-5.
    1. Smitherman TA, McDermott MJ, Buchanan EM. Negative impact of episodic migraine on a university population: quality of life, functional impairment, and comorbid psychiatric symptoms. Headache. 2011;14:581–589. doi: 10.1111/j.1526-4610.2011.01857.x.
    1. Souza-e-Silva HR, Rocha-Filho PA. Headaches and academic performance in university students: a cross-sectional study. Headache. 2011;14:1493–1502. doi: 10.1111/j.1526-4610.2011.02012.x.
    1. Bigal ME, Bigal JM, Betti M, Bordini CA, Speciali JG. Evaluation of the impact of migraine and episodic tension-type headache on the quality of life and performance of a university student population. Headache. 2001;14:710–719. doi: 10.1046/j.1526-4610.2001.041007710.x.
    1. Bicakci S, Bozdemir N, Over F, Saatci E, Sarica Y. Prevalence of migraine diagnosis using ID Migraine among university students in southern Turkey. J Headache Pain. 2008;14:159–163. doi: 10.1007/s10194-008-0031-0.
    1. Baskin SM, Smitherman TA. Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Neurol Sci. 2009;14:61–65. doi: 10.1007/s10072-009-0071-5.
    1. Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D, Forte A, Girardi N, De Filippis S, Tatarelli R, Martelletti P. Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat. 2010;14:81–91.
    1. Innamorati M, Pompili M, Fiorillo M, Lala N, Negro A, Del Bono SD, Lester D, Girardi P, Martelletti P. Overattachment and perceived disability in chronic migraineurs. 2012. Epub ahead of print.
    1. Ferri-de-Barros JE, Alencar MJ, Berchielli LF, Castelhano LC Jr. Headache among medical and psychology students. Arq Neuropsiquiatr. 2011;14:502–508. doi: 10.1590/S0004-282X2011000400018.
    1. Amayo EO, Jowi JO, Njeru EK. Headache associated disability in medical students at the Kenyatta National Hospital. Nairobi East Afr Med J. 2002;14:519–523.
    1. Serafini G, Pompili M, Innamorati M, Gentile G, Borro M, Lamis DA, Lala N, Negro A, Simmaco M, Girardi P, Martelletti P. Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. Eur Rev Med Pharmacol Sci. 2012;14:1389–1398.
    1. Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia. 2004;14:1–159.
    1. Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W. ID Migraine validation study. A self-administered screener for migraine in primary care: the ID migraine validation study. Neurology. 2003;14:375–382. doi: 10.1212/01.WNL.0000078940.53438.83.
    1. Siva A, Zarifoglu M, Ertas M, Saip S, Karli HN, Baykan B, Keskinaslan A, Senocak M. Validity of the ID-migraine screener in the workplace. Neurology. 2008;14:1337–1345. doi: 10.1212/01.wnl.0000309221.85545.0d.
    1. Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003;14:336–342. doi: 10.1046/j.1526-4610.2003.03068.x.
    1. Ertas¸ M, Siva A, Dalkara T, Uzuner N, Dora B, Inan L, Idiman F, Sarica Y, Selçuki D, Sirin H, Oğuzhanoğlu A, Irkec¸ C, Ozmenoğlu M, Ozbenli T, Oztürk M, Saip S, Neyal M, Zarifoğlu M, Turkish MIDAS group. Validity and reliability of the Turkish migraine disability assessment (MIDAS) questionnaire. Headache. 2004;14:786–793. doi: 10.1111/j.1526-4610.2004.04146.x.
    1. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE. Pain measurement: an overview. Pain. 1985;14:1–31.
    1. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders, clinician version (SCID-CV) Washington, DC: American Psychiatric Press Inc; 1996.
    1. Ozkürkçügil A, Aydemir O, Yıldız M, Danacı AE, Köroğlu E. DSM-IV eksen I bozuklukları için yapılandırılmış klinik görüşmenin Tükçeye uyarlanması ve güvenilirlik çalışması. İlac¸ ve Tedavi Dergisi. 1999;14:233–236.
    1. Oztora S, Korkmaz O, Dagdeviren N, Celik Y, Caylan A, Top MS, Asil T. Migraine headaches among university students using ID Migraine test as a screening tool. BMC Neurol. 2011;14:101–103.
    1. Galinović I, Vuković V, Troselj M, Antić S, Demarin V. Migraine and tensiontype headache in medical students: a questionnaire study. Coll Antropol. 2009;14:169–173.
    1. Zwart JA, Dyb G, Holmen TL, Stovner LJ, Sand T. The prevalence of migraine and tension-type headaches among adolescents in Norway. The Nord-Trøndelag Health Study (Head-HUNT-Youth), a large population-based epidemiological study. Cephalalgia. 2004;14:373–379. doi: 10.1111/j.1468-2982.2004.00680.x.
    1. Ojini FI, Okubadejo NU, Danesi MA. Prevalence and clinical characteristics of headache in medical students of the University of Lagos, Nigeria. Cephalalgia. 2009;14:472–477. doi: 10.1111/j.1468-2982.2008.01766.x.
    1. Muftuoglu MN, Herken H, Demirci H, Virit O, Neyal A. Alexithymic features in migraine patients. Eur Arch Psychiatry Clin Neurosci. 2004;14:182–186.
    1. Baskin SM, Smitherman TA. Comorbidity between migraine and depression: update on traditional and alternative treatments. Neurol Sci. 2011;14:9–13.
    1. Low NC, Du Fort GG, Cervantes P. Prevalence, clinical correlates, and treatment of migraine in bipolar disorder. Headache. 2003;14:940–949. doi: 10.1046/j.1526-4610.2003.03184.x.
    1. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry. 1990;14:849–853. doi: 10.1001/archpsyc.1990.01810210057008.
    1. Özdemir Ö. Sivas il merkezinde iki uçlu duygudurum bozukluğunun yaygınlığı, eş tanılar ve hastaların yaşam kalitesinin incelenmesi. Sivas: Yayınlanmamış Uzmanlık Tezi; 2005.
    1. Hamelsky SW, Lipton RB. Psychiatric comorbidity of migraine. Headache. 2006;14:1327–1333. doi: 10.1111/j.1526-4610.2006.00576.x.
    1. Evans RW, Rosen N. Migraine, psychiatric comorbidities and treatment. Headache. 2008;14:952–958. doi: 10.1111/j.1526-4610.2008.01074.x.
    1. Merikangas KR, Merikangas JR, Angst J. Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res. 1993;14:197–210. doi: 10.1016/0022-3956(93)90008-P.
    1. Balaban H, Semiz M, Sentürk IA, Kavakçı O, Cınar Z, Dikici A, Topaktaş S. Migraine prevalence, alexithymia, and post-traumatic stress disorder among medical students in Turkey. J Headache Pain. 2012;14:459–467. doi: 10.1007/s10194-012-0452-7.
    1. de Leeuw R, Schmidt JE, Carlson CR. Traumatic stressors and post-traumatic stress disorder symptoms in headache patients. Headache. 2005;14:1365–1374. doi: 10.1111/j.1526-4610.2005.00269.x.
    1. Peterlin BL, Tietjen G, Meng S, Lidicker J, Bigal M. Posttraumatic stress disorder in episodic and chronic migraine. Headache. 2008;14:517–522. doi: 10.1111/j.1526-4610.2008.00917.x.
    1. Guidetti V, Galli F, Fabrizi P, Giannantoni AS, Napoli L, Bruni O, Trillo S. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia. 1998;14:455–462. doi: 10.1046/j.1468-2982.1998.1807455.x.
    1. Lantéri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain. 2005;14:319–326. doi: 10.1016/j.pain.2005.09.010.
    1. Pompili M, Serafini G, Innamorati M, Serra G, Dominici G, Fortes-Lindau J, Pastina M, Telesforo L, Lester D, Girardi P, Tatarelli R, Martelletti P. Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat Outcome Meas. 2010;14:107–118.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir